## **Core Concept**
Hepatitis C virus (HCV) testing in blood banks is crucial to prevent transfusion-transmitted hepatitis C. The primary goal is to detect HCV infection with high sensitivity and specificity to ensure blood safety.

## **Why the Correct Answer is Right**
The correct answer, ** Nucleic Acid Testing (NAT)**, is considered the gold standard for HCV screening in blood banks due to its high efficacy. NAT directly detects the genetic material of the virus (RNA), allowing for early detection even before antibodies are produced. This is particularly important for identifying acute infections where the individual may not have developed antibodies yet.

## **Why Each Wrong Option is Incorrect**
- **Option A: ELISA (Enzyme-Linked Immunosorbent Assay)**: While ELISA is commonly used for screening, it detects antibodies against HCV, not the virus itself. It may not detect acute infections before antibody development.
- **Option B: Rapid Diagnostic Tests**: These tests are quick but generally less sensitive than NAT or ELISA and are not typically used for blood bank screening.
- **Option D: Liver Function Tests (LFTs)**: LFTs can indicate liver damage but are not specific for HCV infection and cannot be used for screening.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Nucleic Acid Testing (NAT) for HCV** significantly reduces the window period (the time between infection and when the test can detect it), making it a critical tool in ensuring the safety of blood supplies.

## **Correct Answer: C. Nucleic Acid Testing (NAT)**